High 2-[18F]fluoro-2-deoxy-d-glucose (18FDG) uptake measured by positron emission tomography is associated with reduced overall survival in patients with oral squamous cell carcinoma

Oral Oncology

Volumn 45, Issue 11, 2009, Pages 963-967

  Hofele, Christof ^a   Freier, Kolja ^a   Thiele, Oliver C ^a   Haberkorn, Uwe ^a   Buchmann, Inga ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

18FDG; Oral squamous cell carcinoma; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG TISSUE LEVEL; DRUG UPTAKE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA; TUMOR LOCALIZATION; METABOLISM; METHODOLOGY; MIDDLE AGED; MORTALITY; MOUTH TUMOR; PROGNOSIS; RETROSPECTIVE STUDY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 70349973248     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2009.06.008     Document Type: Article

References (25)

1. Funk G.F., Karnell L.H., Robinson R.A., Zhen W.K., Trask D.K., and Hoffman H.T. Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report. Head Neck 24 2 (2002) 165-180
2. Weinberg M.A., and Estefan D.J. Assessing oral malignancies. Am Fam Physician 65 7 (2002) 1379-1384
3. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics, 2007. CA Cancer J Clin 57 1 (2007) 43-66
4. Schwartz D.L., Rajendran J., Yueh B., Coltrera M.D., Leblanc M., Eary J., et al. FDG-PET prediction of head and neck squamous cell cancer outcomes. Arch Otolaryngol Head Neck Surg 130 12 (2004) 1361-1367
5. Allal A.S., Slosman D.O., Kebdani T., Allaoua M., Lehmann W., and Dulguerov P. Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-d-glucose. Int J Radiat Oncol Biol Phys 59 5 (2004) 1295-1300
6. McCollum A.D., Burrell S.C., Haddad R.I., Norris C.M., Tishler R.B., Case M.A., et al. Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer. Head Neck 26 10 (2004) 890-896
7. Kim S.Y., Roh J.L., Kim M.R., Kim J.S., Choi S.H., Nam S.Y., et al. Use of 18F-FDG PET for primary treatment strategy in patients with squamous cell carcinoma of the oropharynx. J Nucl Med 48 5 (2007) 752-757
8. Huang Q., Yu G.P., McCormick S.A., Mo J., Datta B., Mahimkar M., et al. Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression. Gene Chromosome Cancer 34 2 (2002) 224-233
9. Freier K., Joos S., Flechtenmacher C., Devens F., Benner A., Bosch F.X., et al. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma. Cancer Res 63 6 (2003) 1179-1182
10. Patmore H.S., Ashman J.N., Stafford N.D., Berrieman H.K., MacDonald A., Greenman J., et al. Genetic analysis of head and neck squamous cell carcinoma using comparative genomic hybridisation identifies specific aberrations associated with laryngeal origin. Cancer Lett 258 1 (2007) 55-62
11. Kim S.Y., Roh J.L., Kim J.S., Ryu C.H., Lee J.H., Cho K.J., et al. Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity. Eur J Surg Oncol 34 2 (2008) 208-215
12. Ng S.H., Yen T.C., Liao C.T., Chang J.T., Chan S.C., Ko S.F., et al. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med 46 7 (2005) 1136-1143
13. Lorenzen S., Herrmann K., Weber W.A., Wieder H., Hennig M., Ott K., et al. Visualisation of metastatic oesophageal and gastric cancer and prediction of clinical response to palliative chemotherapy using 18FDG PET. Nuklearmedizin 46 6 (2007) 263-270
14. Yamazaki Y., Saitoh M., Notani K., Tei K., Totsuka Y., Takinami S., et al. Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer. Ann Nucl Med 22 3 (2008) 177-184
15. Schoder H., Carlson D.L., Kraus D.H., Stambuk H.E., Gonen M., Erdi Y.E., et al. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med 47 5 (2006) 755-762
16. Kyzas P.A., Evangelou E., Denaxa-Kyza D., and Ioannidis J.P. 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. J Natl Cancer Inst 100 10 (2008) 712-720
17. Halfpenny W., Hain S.F., Biassoni L., Maisey M.N., Sherman J.A., Mc Gurk M., et al. FDG-PET. A possible prognostic factor in head and neck cancer. Br J Cancer 86 4 (2002) 512-516
18. Allal A.S., Dulguerov P., Allaoua M., Haenggeli C.A., El-Ghazi el A., Lehmann W., et al. Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy. J Clin Oncol 20 5 (2002) 1398-1404
19. Freier K., Engel M., Lindel K., Flechtenmacher C., Muhling J., Hassfeld S., et al. Neoadjuvant concurrent radiochemotherapy followed by surgery in advanced oral squamous cell carcinoma (OSCC): a retrospective analysis of 207 patients. Oral Oncol 44 2 (2008) 116-123
20. Soret M., Bacharach S.L., and Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med 48 6 (2007) 932-945
21. Forastiere A, Goepfert H, Goffinet D, Hong KW, Laramore G, Mittal B, et al. NCCN practice guidelines for head and neck cancer. National Comprehensive Cancer Network. Oncology (Williston Park) 1998;12(7A):39-147.
22. Bernier J., Domenge C., Ozsahin M., Matuszewska K., Lefebvre J.L., Greiner R.H., et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. New Engl J Med 350 19 (2004) 1945-1952
23. Porceddu S.V., Campbell B., Rischin D., Corry J., Weih L., Guerrieri M., et al. Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 60 2 (2004) 365-373
24. Schultze-Mosgau S., Grabenbauer G.G., Wehrhan F., Radespiel-Troger M., Wiltfang J., Sauer R., et al. Histomorphological structural changes of head and neck blood vessels after pre- or postoperative radiotherapy. Strahlenther Onkol 178 6 (2002) 299-306
25. Jellema A.P., Doornaert P., Slotman B.J., Leemans C.R., and Langendijk J.A. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?. Radiother Oncol 77 2 (2005) 164-171